Opioid medications are one solution for chronic pain relief. While there is concern over whether they are addictive, this apprehension has grown out of proportion to the actual risk and overshadows the benefits of opioids, which provide long-lasting relief with relatively harmless long-term side effects.
On October 6, 2014 new federal regulations on drugs that contain hydrocodone will take effect. Under the new ruling, hydrocodone combination products (HCPs) will be reclassified from Schedule III to the more restrictive Schedule II. More than 60 different products will be affected by this ruling. Two of the most familiar brand names are Vicodin…